UK-based private equity firm Capital International has acquired 3% stake in Indian pharmaceutical company Intas Pharmaceuticals.
The stake was purchased from Mauritius-based private equity firm ChrysCapital for Rs6.9bn ($106.3m) consideration.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Apollo Capital has increased its stake in US-based biotechnology company GLG Pharma to 11.33% by acquiring an additional 7.5% stake.
The acquirer company is a private equity firm.
